Suruchi Mittal

884 total citations
7 papers, 641 citations indexed

About

Suruchi Mittal is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Suruchi Mittal has authored 7 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Suruchi Mittal's work include Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Suruchi Mittal is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Suruchi Mittal collaborates with scholars based in Italy, India and Croatia. Suruchi Mittal's co-authors include Lawrence Banks, Nicola J. Brown, Ingunn Holen, Rekha V. Kumar, Annapoorni Rangarajan, Paola Massimi, Devaveena Dey, Deepa Subramanyam, Anita Szalmás and Vjekoslav Tomaić and has published in prestigious journals such as Journal of Virology, PLoS Pathogens and Molecular Cancer.

In The Last Decade

Suruchi Mittal

7 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suruchi Mittal Italy 7 331 242 198 143 116 7 641
Christopher W. Wasson United Kingdom 16 324 1.0× 190 0.8× 263 1.3× 172 1.2× 218 1.9× 34 795
Cristina Chamizo Spain 13 266 0.8× 263 1.1× 161 0.8× 92 0.6× 110 0.9× 26 692
Runliang Gan China 15 363 1.1× 299 1.2× 134 0.7× 235 1.6× 169 1.5× 32 806
Rancés Blanco Cuba 15 303 0.9× 237 1.0× 107 0.5× 59 0.4× 206 1.8× 45 607
Tehila Hyman Israel 11 279 0.8× 118 0.5× 201 1.0× 114 0.8× 198 1.7× 12 592
Masahiko Ajiro Japan 15 641 1.9× 129 0.5× 153 0.8× 178 1.2× 102 0.9× 28 809
Nicole A. Spardy United States 10 300 0.9× 227 0.9× 220 1.1× 87 0.6× 27 0.2× 10 504
Angela Kwok Fung Lo Hong Kong 10 477 1.4× 575 2.4× 111 0.6× 331 2.3× 181 1.6× 10 968
Alissa M. Wong Hong Kong 10 442 1.3× 188 0.8× 165 0.8× 376 2.6× 51 0.4× 17 739
Siribang-on Piboonniyom United States 7 320 1.0× 287 1.2× 254 1.3× 79 0.6× 55 0.5× 7 696

Countries citing papers authored by Suruchi Mittal

Since Specialization
Citations

This map shows the geographic impact of Suruchi Mittal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suruchi Mittal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suruchi Mittal more than expected).

Fields of papers citing papers by Suruchi Mittal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suruchi Mittal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suruchi Mittal. The network helps show where Suruchi Mittal may publish in the future.

Co-authorship network of co-authors of Suruchi Mittal

This figure shows the co-authorship network connecting the top 25 collaborators of Suruchi Mittal. A scholar is included among the top collaborators of Suruchi Mittal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suruchi Mittal. Suruchi Mittal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Basukala, Om, Suruchi Mittal, Paola Massimi, Marco Bestagno, & Lawrence Banks. (2019). The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells. PLoS Pathogens. 15(5). e1007769–e1007769. 30 indexed citations
2.
Mittal, Suruchi, Nicola J. Brown, & Ingunn Holen. (2018). The breast tumor microenvironment: role in cancer development, progression and response to therapy. Expert Review of Molecular Diagnostics. 18(3). 227–243. 142 indexed citations
3.
Szalmás, Anita, Vjekoslav Tomaić, Om Basukala, et al.. (2017). The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7. Journal of Virology. 91(7). 64 indexed citations
4.
Mittal, Suruchi & Lawrence Banks. (2016). Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutation Research/Reviews in Mutation Research. 772. 23–35. 138 indexed citations
5.
Broniarczyk, Justyna, Paola Massimi, Suruchi Mittal, et al.. (2015). The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy. Viruses. 7(7). 3530–3551. 105 indexed citations
6.
Mittal, Suruchi, Ankur Sharma, Sai A. Balaji, et al.. (2014). Coordinate Hyperactivation of Notch1 and Ras/MAPK Pathways Correlates with Poor Patient Survival: Novel Therapeutic Strategy for Aggressive Breast Cancers. Molecular Cancer Therapeutics. 13(12). 3198–3209. 46 indexed citations
7.
Mittal, Suruchi, Deepa Subramanyam, Devaveena Dey, Rekha V. Kumar, & Annapoorni Rangarajan. (2009). Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Molecular Cancer. 8(1). 128–128. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026